We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUE
3626
DELISTED
TrueCar
TRUE
$226K ﹤0.01%
28,824
-39,507
-58% -$262K
NSM
3627
CALL
DELISTED
Nationstar Mortgage Holdings
NSM
$226K ﹤0.01%
+20,100
New +$233K
RIC
3628
DELISTED
Richmont Mines Inc.
RIC
$225K ﹤0.01%
+24,391
New +$190K
SRGA
3629
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$224K ﹤0.01%
+2,081
New +$244K
CSS
3630
DELISTED
CSS Industries, Inc.
CSS
$224K ﹤0.01%
+8,328
New +$228K
LEN.B icon
3631
Lennar Class B
LEN.B
$20.2B
$223K ﹤0.01%
+6,431
New +$220K
MCFT icon
3632
MasterCraft Boat Holdings
MCFT
$596M
$223K ﹤0.01%
+20,189
New +$265K
UUUU icon
3633
Energy Fuels
UUUU
$2.73B
$223K ﹤0.01%
+98,090
New +$228K
GOL
3634
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$223K ﹤0.01%
105,585
-22,580
-18% -$34.2K
MRTX
3635
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$223K ﹤0.01%
40,787
+26,191
+179% +$417K
PRTY
3636
DELISTED
Party City Holdco Inc.
PRTY
$223K ﹤0.01%
16,080
-33,052
-67% -$455K
MHGC
3637
DELISTED
Morgans Hotel Group Co.
MHGC
$223K ﹤0.01%
+104,151
New +$196K
ARAV
3638
DELISTED
Aravive, Inc. Common Stock
ARAV
$222K ﹤0.01%
3,331
+1,656
+99% +$94.1K
BGFV
3639
DELISTED
Big 5 Sporting Goods
BGFV
$221K ﹤0.01%
23,873
+5,947
+33% +$58.2K
JPN
3640
DELISTED
Xtrackers Japan JPX-Nikkei 400 Equity ETF
JPN
$221K ﹤0.01%
+9,774
New +$222K
TVIA
3641
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$221K ﹤0.01%
+84,243
New +$196K
EPR.PRE icon
3642
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$115M
$220K ﹤0.01%
5,880
-3,720
-39% -$130K
VSEC icon
3643
VSE Corp
VSEC
$5.17B
$220K ﹤0.01%
6,588
-17,976
-73% -$604K
CHGG icon
3644
Chegg
CHGG
$118M
$219K ﹤0.01%
43,875
+23,128
+111% +$107K
FPI
3645
Farmland Partners
FPI
$415M
$219K ﹤0.01%
+19,320
New +$213K
PNF
3646
DELISTED
PIMCO New York Municipal Income Fund
PNF
$219K ﹤0.01%
15,500
CVLG icon
3647
Covenant Logistics
CVLG
$1.06B
$217K ﹤0.01%
23,922
+1,578
+7% +$16.8K
TBHC
3648
DELISTED
The Brand House Collective
TBHC
$217K ﹤0.01%
14,854
-18,088
-55% -$272K
NAVB
3649
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$217K ﹤0.01%
20,421
+19,411
+1,922% +$381K
CYTK icon
3650
Cytokinetics
CYTK
$10.7B
$216K ﹤0.01%
22,839
-5,421
-19% -$44.5K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.